Gamida Cell Ltd (GMDA)
Sector • Healthcare Industry • Biotechnology & Pharmaceuticals |
Industry • Biotechnology & Pharmaceuticals |
Sector • Healthcare |
News
Gamida Cell Announces Restructuring Plan with Backing from Highbridge Capital Management
Gamida Cell Ltd Reports Strong Operating Profit in Second Quarter of 2023
Gamida Cell Ltd published operating profit of $20.563 millions, in the October to December 31 2022
Existing costs have been growing at the GMDA in the July to September 30 2022 interval